Flu Vaccine: How a High Dose Could Help Older Patients
The flu can be a major risk for elderly patients. But the type of flu vaccine these patients receive could lower that risk.
Flu Season Is Here: What You Need To Know
The colder months have finally arrived, and that means it's flu season. But with a few simple steps, you can help protect yourself from catching this nasty virus.
New Flu Rx on the Horizon
Newfound support may give an experimental flu medication the boost it needs to become available for use.
Flu Vaccine Q&A
You asked, we answered! Check out this list of top questions about flu season.
How Your Flu Vaccine May Protect Those Around You
Adults who get their yearly flu vaccines may wind up protecting more than just themselves.
Why Early Flu Treatment Matters
The flu can be particularly dangerous for seniors, but early treatment with one kind of medication may help.
This Flu Rx May Really Work
Coughing, fever, aches and pains. Flu symptoms can be miserable. Good news, though — a medication may shorten that misery.
Common Cold and Flu Myths
With cold and flu season well underway, popular myths about these unwanted holiday visitors are circulating along with the sniffles.
Influenza is an Epidemic in 22 States
As more states report flu cases and hospitalizations climb, the Centers for Disease Control and Prevention (CDC) has declared the flu an epidemic.
BioCryst's Rapivab Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza
BioCryst Pharmaceuticals, Inc., (Nasdaq:BCRX) a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase inhibitor for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.